Citeline Alternative: Clinical Trial Monitoring Without the Sales Call

Citeline and Evaluate Pharma are intelligence platforms for pharma: neither publishes a price, and both route you to a demo or a specialist. DataLookout covers the ClinicalTrials.gov monitoring layer for $49/month, with no contract and a 2-minute setup.

Citeline does not publish a price. DataLookout starts at $0.

Not published

Citeline

vs.

$49/mo

DataLookout Starter

Daily change tracking, a free tier to start, and no procurement process.

Who actually looks for a Citeline alternative

Someone at a clinical-stage biotech described the usual setup as the BD team catching things by hand, Google Alerts, or a patchwork of ClinicalTrials.gov RSS feeds with an intern checking them, and said the registry's volume of weekly amendments makes the real problem signal-to-noise. A reply from the big-pharma side named Citeline TrialTrove as what CI teams use instead. (r/biopharma thread, March 2026)
An independent consultant wanted a single-user, cost-effective tool to scan pipelines, saying most offerings run to tens of thousands of dollars. (r/biotech thread, October 2024)
A Citeline power user called it clunky but very useful. Our summary: the enterprise platforms are good, and they are priced and sold for enterprises. (r/biotech thread, November 2023)

DataLookout is the ClinicalTrials.gov change layer for the first two: one seat, $49/month for Starter, a free tier to start, and the diff done for you instead of by the intern. It does not carry Citeline's enriched multi-source data.

Citeline and Evaluate Pharma vs DataLookout

Feature	Citeline	Evaluate Pharma	DataLookout
Clinical trial data	Yes: Trialtrove, analyst-curated	Not mentioned on the product page	Yes: ClinicalTrials.gov, daily scan
Change alerts by email	Not mentioned	Not mentioned	Built-in, default
Data source	Analyst-curated; Trialtrove cites 60,000+ sources (its figure)	Consensus forecasts, sales data, deals	ClinicalTrials.gov
Setup	Demo or specialist request	Demo or specialist request	2 minutes
Contract	Not stated on the product page	Not stated on the product page	No: month-to-month
Starting price	Not published	Not published	Free, then $49/month

What Citeline and Evaluate Pharma offer

Citeline (a Norstella company) and Evaluate Pharma are intelligence platforms for pharma. Their product pages (checked August 22, 2026) describe:

Citeline: analyst-curated clinical products (Trialtrove, Sitetrove, Pharmaprojects); Trialtrove cites 60,000+ sources (its figure)
Evaluate Pharma: consensus sales forecasts for almost 6,000 drugs, historic sales data, deal monitoring, development and regulatory timelines, patent-expiry dates (its figures)
Both: sold through a demo or a specialist, no published price, no free tier mentioned

Neither publishes a price.

The gap the enterprise platforms leave

Neither platform publishes a price, and both route you to a sales conversation before you can start. That leaves a gap for:

Small and mid-size biotechs that want a seat without a procurement process
Individual BD professionals who want monitoring on a personal budget
Academic medical centers tracking clinical programs in their disease areas
Investors who want trial status monitoring without a full enterprise intelligence subscription
Teams that need the ClinicalTrials.gov monitoring layer and not the financial data or analyst forecasts

DataLookout is built for this gap. We don't try to replicate everything Citeline does. We do one thing well: monitor ClinicalTrials.gov daily and tell you what's new in the areas you care about.

How DataLookout handles the monitoring layer

Daily scan of ClinicalTrials.gov

Every day, DataLookout takes a fresh snapshot of the ClinicalTrials.gov records it monitors and compares each one to the previous day's version. The diff engine tracks 12 fields, including overall status, enrollment, primary endpoints, interventions, results posting, site counts, and completion dates, and classifies every change as critical, notable, or minor.

Watchlists and saved searches

You choose what to monitor: watch a sponsor, watch a disease area, or save a search with the filters you care about. The free plan includes 1 sponsor + 1 disease watchlist and 1 saved search, free forever. Starter raises the limits to 3 of each, and Pro is unlimited.

Email digest and dashboard inbox

Changes reach you two ways: a morning email digest for your watchlists, and an inbox in the dashboard where you can review each change and mark it seen or done. Every change links to the trial's detail page, which shows the change history and links back to the ClinicalTrials.gov record.

Which tool fits which job?

DataLookout, if:

You primarily need to monitor ClinicalTrials.gov for competitive intelligence and don't need financial forecasts or deal databases. You're a small/mid biotech, individual BD professional, or investor who wants public pricing. You want daily alerts that arrive in your inbox without logging into another platform.

Citeline or Evaluate Pharma, if:

You need consensus sales forecasts, deal data, or analyst-curated trial and site intelligence in one platform.

FAQ

Frequently asked questions

Does DataLookout cover the same trials as Citeline?

Not one-for-one. Citeline's clinical products are curated by analysts (Trialtrove cites 60,000+ sources, its figure, checked August 22, 2026) and the product pages do not name their registries. DataLookout reads the ClinicalTrials.gov registry directly and delivers its records clean, daily, and filterable, without an enrichment layer.

Can I use DataLookout alongside Citeline?

Yes. If you have Citeline, DataLookout adds a daily change layer: the morning email says what moved in the trials you watch, without logging into a separate platform. At $49/month it adds that coverage to teams that already have, or are between, enterprise subscriptions.

How current is the data?

DataLookout scans ClinicalTrials.gov daily, so registry updates typically appear in your dashboard and digest within 24 hours of posting. The registry is the authoritative source: federal regulation (42 CFR 11.64, checked 2026-08-20) requires key fields such as overall recruitment status and primary completion date to be updated within 30 days of a change, and other registration information at least every 12 months.

What if I cancel?

Cancel any time: no annual contract, no cancellation fee. Your digests stop at the end of the billing period. Email support@datalookout.com to cancel or change your plan.

Related resources

Try DataLookout free

1 sponsor + 1 disease watchlist with daily change detection. Free forever, no credit card.

Get started free